학술논문

An open-label, dose-escalation phase I study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 November 2016, 22(21):5204-5210)
Subject
Language
English
ISSN
15573265
10780432